[Clinical characteristics and operative effect of XXXX ].

@entity1 @entity1158 @entity410 @entity227 @entity66 @entity18349 @entity75 @entity5 @entity1373 @entity11 @entity1463 @entity6795 @entity86 @entity204 @entity9872
OBJECTIVE: To study the clinical characteristics and operative effect of @entity75 . METHODS: We retrospectively analyzed the clinical characteristics and operative outcome of 44 @entity1 with @entity75 between August 2005 and April 2010. RESULTS: @entity410 attack was the initial symptom among 40 of the 44 @entity1 . Pathological examinations revealed 18 @entity11 , 9 cavernous malformations, 12 @entity1463 , 2 focal @entity6795 , 1 @entity1373 , 1 @entity66 , and 1 @entity9872 . Thirteen @entity1 received anterior medial temporal lobectomy and the other 31 received lesionectomy or selective amygdalohippocampectomy via transsylvian approach. An average of 15.7 month follow-up was accomplished in 37 @entity1 . @entity86 outcomes were evaluated according to Engel classification: Grade I 73.0%(27/37), Grade II 13.5%(5/37), Grade @entity18349 .8%(4/37) and Grade IV 2.7%(1/37). No perioperative @entity204 occurred. One @entity1 experienced @entity1158 but recovered 8 months after the operation. Noticeable postoperative @entity227 was left in 2 @entity1 . Two @entity1 with @entity11 died of remote @entity5 recurrence during follow-up. CONCLUSION: @entity410 attack is a major complaint of @entity75 . Satisfactory @entity410 and @entity5 control may be achieved through anterior medial temporal lobectomy or selective amygdalohippocampectomy with lesionectomy.
